RIGL Return on Tangible Equity | RIGEL PHARMACEUTICALS, INC.

RIGEL PHARMACEUTICALS, INC. (RIGL) Return on Tangible Equity

2026-06-30: Return Tang Equity 97.09%.
2026-03-31: Return Tang Equity 96.94%.
2025-12-31: Return Tang Equity 100.08%.
2025-09-30: Return Tang Equity 122.79%.

Complete source-backed return tang equity history.

Available history: 2015-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	97.09%
2026-03-31	96.94%
2025-12-31	100.08%
2025-09-30	122.79%
2025-06-30	174.65%
2025-03-31	-467.94%
2024-12-31	-73.43%
2024-09-30	-9.17%
2024-06-30	24.46%
2024-03-31	32.71%
2023-12-31	59.01%
2023-09-30	52.21%
2023-06-30	87.71%
2023-03-31	113.92%
2022-12-31	205.05%
2022-09-30	416.53%
2022-06-30	2298.88%
2022-03-31	-1248.29%
2021-12-31	-58.98%
2021-09-30	-29.21%
2021-06-30	-11.35%
2021-03-31	34.91%
2020-12-31	-86.31%
2020-09-30	-54.42%
2020-03-31	-13.16%
2019-12-31	-103.98%
2019-03-31	-67.80%
2018-12-31	-56.74%
2018-03-31	-101.70%
2017-12-31	-77.75%
2017-03-31	-30.15%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	100.08%
2024-12-31	-73.43%
2023-12-31	59.01%
2022-12-31	205.05%
2021-12-31	-58.98%
2020-12-31	-87.42%
2019-12-31	-124.30%
2018-12-31	-64.14%
2017-12-31	-77.49%
2016-12-31	-125.79%
2015-12-31	-56.32%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Apnimed, Inc. (APMD)	United States	$0.899B
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
Arbutus Biopharma Corp (ABUS)		$0.965B	6.19